SCHEMBL31020122

SCHEMBL31020122

CC(C)(C)OC(=O)N1CCC[C@@H](Nc2nnc(-c3ccc(C(F)(F)F)cc3OCc3ccccc3)n3ccnc23)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 4/20 0.43
▸ TRPV1 Q8NER1 1/20 0.41
▸ TACR1 P25103 1/20 0.40
▸ BRD4 O60885 1/20 0.40
▸ CCNT1 O60563 1/20 0.40
▸ CCNA2 P20248 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ CDK9 P50750 1/20 0.40
▸ CCNA1 P78396 1/20 0.40
▸ RXRA P19793 1/20 0.39
▸ RXRB P28702 1/20 0.39
▸ RXRG P48443 1/20 0.39
▸ IL1B P01584 2/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ PIM1 P11309 2/20 0.38
▸ PIM2 Q9P1W9 2/20 0.38
▸ BTK Q06187 3/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ PRMT5 O14744 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31020094 0.90 RXRA (0.39) TACR1BRD4CCNT1CCNA2CDK2
SCHEMBL31020113 0.87 IL1B (0.50) RXRARXRBRXRGIL1BBTK
SCHEMBL31020047 0.85 PRMT5 (0.45) USP30TRPV1TACR1CCNT1CCNA2
SCHEMBL31020044 0.84 IL1B (0.39) RXRARXRBRXRGIL1BBTK
SCHEMBL31020065 0.84 IL1B (0.40) RXRARXRBRXRGIL1BBTK
SCHEMBL31034947 0.81 TACR1 (0.42) USP30TRPV1TACR1BRD4CCNT1
SCHEMBL31020067 0.81 HTR2C (0.41) RXRARXRBRXRGIL1BPIM1
SCHEMBL31020053 0.77 NLRP3 (0.43) IL1B
SCHEMBL31020042 0.76 IL1B (0.38) IL1BHDAC4HDAC6PIM1PIM2
SCHEMBL29276023 0.76 TRPV1 (0.44) USP30TRPV1TACR1BRD4IL1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658653-A1 IMIDAZO[1,2-D][1,2,4]TRIAZINES AS NLRP3 INHIBITORS Janssen Pharmaceutica NV (BE) 2025-12-10 — — EP disclosed
WO-2024160692-A1 IMIDAZO[1,2-D][1,2,4]TRIAZINES AS NLRP3 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2024-08-08 — — WO disclosed
Send feedback